FDA Adverse Event Malfunction Summary report: N

ID CORE XT

MDR report key: 10341883 · Received July 29, 2020

Report

Report Number
3006413195-2020-00010
Event Type
Malfunction
Date Received
July 29, 2020
Date of Event
June 27, 2020
Report Date
June 29, 2020
Manufacturer
PROGENIKA BIOPHARMA S.A.
Product Code
PEP
UDI-DI
08437013457019
PMA / PMN Number
BP170154
Removal / Correction Number
N/A
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE GENOMIC DNA SAMPLE WAS SENT TO GRIFOLS IH CENTER FOR SEQUENCING. NEXT GENERATION SEQUENCING INTERROGATED RH GENES PROXIMAL PROMOTER, EXONS 1-10, AND PORTIONS OF INTRON 2-3. NO VARIANT WAS FOUND IN RH GENES AND SEQUENCING PROVIDED A GENOTYPE RHCE*CE, RHCE*CE, BUT ID CORE XT REPORTED A GENOTYPE RHCE*CE, RHCE*CE. ID CORE XT DETERMINES C/C ANTIGENS INTERROGATING POLYMORPHISM RHCE: C.335+3039INS109 IN RHCE GENE INTRON 2. THE PRESENCE OF THE 109 BP INSERT IS ASSOCIATED WITH C ANTIGEN. HOWEVER, THIS SAMPLE CARRIES A RARE ALLELE DESCRIBED BY ISBT AS RHCE*02.37 THAT PROVIDES A C+ PHENOTYPE BY LACKS THE 109 BP INSERT. ID CORE XT REPORTED A PREDICTED C- PHENOTYPE, BUT THE SEROLOGY DATA FROM THE USER IS C+, DUE TO THE PRESENCE OF RARE RHCE*02.37 ALLELE. SINCE ID CORE XT OBTAINED A FALSE NEGATIVE RESULT, THIS IS CONSIDERED A DISCREPANT RESULT AND THEN A MALFUNCTION. THIS LIMITATION IS COVERED BY THE GENERAL ASSAY LIMITATION DESCRIBED IN THE ID CORE XT PACKAGE INSERT (LIMITATION 1).

Description of Event or Problem · 1

THE CUSTOMER REPORTED A POSSIBLE DISCREPANCY. THE SEROLOGICAL PHENOTYPE WAS C POSITIVE AND THE ID CORE XT GENOTYPE SUGGESTED A PHENOTYPE OF C NEGATIVE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
801862 ID CORE XT ID CORE XT PEP PROGENIKA BIOPHARMA S.A. 1021720000 0203000019 08437013457019

Patients

Seq Age Sex Outcome Treatment
1